Advertisement
Original report| Volume 3, ISSUE 3, P130-135, March 1999

Fatal dengue hemorrhagic fever in Cuba, 1997

Open ArchiveDOI:https://doi.org/10.1016/S1201-9712(99)90033-4
Fatal dengue hemorrhagic fever in Cuba, 1997
Previous ArticleBiomass cooking fuels and prevalence of tuberculosis in India
Next ArticleImported malaria in a Singapore Hospital: Clinical presentation and outcome
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Objectives: After more than 15 years without dengue activity, a dengue II epidemic was reported in Cuba in 1997. Three thousand and twelve serologically confirmed cases were reported, with 205 dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) cases and 12 fatalities. This report presents the clinical, serologic, and virologic findings in the 12 fatal DHF/DSS cases.
      Methods: Serum and necropsy samples were studied by viral isolation in C636 cell line and polymerase chain reaction. Serum samples were tested by IgM capture enzyme-linked immunoassay (ELISA) and ELISA inhibition method (EIM).
      Results: All 12 cases were classified as DHF/DSS according to the Pan American Health Organization Guidelines for Control and Prevention of Dengue and Dengue Hemorrhagic Fever in the Americas. All patients were older than 15 years. Women were more frequently affected. The symptoms and signs presented by these patients were similar to those previously described in DHF/DSS cases. Clinical deterioration occurred on average at day 3.75. Abdominal pain and persistent vomiting were the earliest and most frequent warning signs. Dengue infection was confirmed in all cases. IgM antibodies were detected in 11 of 12 cases, all of them with a secondary infection. Dengue II virus was detected by viral isolation in 12 samples and by polymerase chain reaction in 17. Virus or RNA was detected in various tissues, including kidney, heart, lung, and brain.
      Conclusion: The clinical, pathologic, and laboratory features of 12 cases of fatal dengue hemorrhagic fever were reviewed. The results obtained demonstrate that adults with a primary dengue infection are at risk of developing the severe disease ( (DHF) if they are infected with a different serotype.

      Keywords

      References

        • Kourí G.
        • Guzmán M.G.
        • Valdés L.
        • et al.
        Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba.
        Emerg Infect Dis. 1998; 4: 89-92
        • Kourí G.
        • Guzmán M.G.
        • Bravo J.
        • Triana C.
        Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981.
        Bull WHO. 1989; 67: 375-380
        • Cantelar N.
        • Fernández A.
        • Albert L.
        • Pérez E.
        Circulación de dengue en Cuba 1978–1979.
        Rev Cubana Med Trop. 1981; 33: 72-78
        • Kourí G.
        • Más P.
        • Guzmán M.G.
        • Soler M.
        • Goyenechea A.
        • Morier L.
        Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent.
        Bull Pan Am Health Organ. 1983; 17: 126-132
        • Pan American Health Organization
        Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control.
        PAHO, Washington, DC1994 (Scientific Publication 548)
        • Vázquez S.
        • Saenz E.
        • Huelva G.
        • González A.
        • Kourí G.
        • Guzmán M.G.
        Detección de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro.
        Rev Panam Salud Publica. 1998; 3: 174-178
        • Fernández R.
        • Vázquez S.
        Serological diagnosis of dengue by an ELISA inhibition method (EIM).
        Mem Inst Oswaldo Cruz. 1990; 85: 345-351
        • Vázquez S.
        • Bravo J.
        • Pérez A.B.
        • Guzmán M.G.
        ELISA de inhibición. Una alternativa en el estudio serológico de los cases de dengue.
        Bol Epidem OPS. 1997; 18: 7-8
        • Lanciotti R.S.
        • Calisher C.H.
        • Gubler D.G.
        • Chang G.
        • Vordam V.
        Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.
        J Clin Microbiol. 1992; 30: 545-551
        • Rosario D.
        • Alvarez M.
        • Díaz J.
        • Contreras R.
        • Rodriguez R.
        • Vázquez S.
        • Guzmán M.G.
        Reacción en cadena de la polimerasa para la rápida detección y determinación del serotipo de virus de dengue en muestras clinicas.
        Rev Panam Salud Publica. 1998; 4: 1-5
        • Díaz A.
        • Kourí G.
        • Guzmán M.G.
        • et al.
        Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults.
        Bull Pan Am Health Organ. 1988; 22: 133-144
        • Rigau J.G.
        • Puerto Rico Association of Epidemiologists
        Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990–1991.
        Rev Panam Salud Publica. 1997; 1: 381-388
        • Monath T.P.
        Yellow fever and dengue: the interactions of virus, vector and host in the re-emergence of epidemic disease.
        Semin Virology. 1994; 5: 133-145
        • Gubler D.
        • Clark G.
        Dengue/dengue hemorrhagic fever: the emergence of a global health problem.
        Emerg Infect Dis. 1995; 1: 55-57
        • Gubler D.J.
        • deCock K.
        Population growth urbanization, automobiles, and airplanes: the dengue connection.
        in: Greenwood B. New and resurgent infections: prediction, detection, and management of tomorrow's epidemics. Wiley & Sons, New York1998
        • Nimmannitya S.
        Management of dengue and dengue haemorrhagic fever.
        in: Monograph on dengue/dengue haemorrhagic fever. Regional publication SEARO No. 22. WHO Regional Office for South-East Asia, New Delhi1993: 48-54
        • Jatanasen S.
        • Thongcharoen E.
        Dengue haemorrhagic fever in south-east Asian countries.
        in: Monograph on dengue/dengue haemorrhagic fever. Regional publication SEARO No. 22. WHO Regional Office for South-East Asia, New Delhi1993: 23-30
        • Sumarmo
        • Wulur H.
        • Jahja E.
        • Gubler D.J.
        • Suharyono W.
        • Sorensen K.
        Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia.
        Bull WHO. 1993; 61: 693-701
        • Nimmannitya S.
        Clinical spectrum and management of dengue haemorrhagic fever.
        Southeast Asian J Trop Med Public Health. 1987; 18: 392-397
        • Zagne S.M.O.
        • Alves V.G.F.
        • Nogueira R.M.R.
        • Miagostovich M.P.
        • Lampe E.
        • Tavares W.
        Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases.
        Trans R Soc Trop Med Hyg. 1994; 88: 677-679
        • Guzmán M.G.
        • Kourí G.
        • Martínez E.
        • et al.
        Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).
        Bull Pan Am Health Organ. 1987; 21: 270-279
        • Guzmán M.G.
        • Kourí G.
        • Morier L.
        • Soler M.
        • Fernandez A.
        A study of fatal hemorrhagic dengue cases in Cuba, 1981.
        Bull Pan Am Health Organ. 1984; 18: 213-220
        • Halstead S.B.
        Pathogenesis of dengue. Challenges to molecular biology.
        Science. 1988; 239: 475-481
        • Bravo J.
        • Guzmán M.G.
        • Kourí G.
        Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults.
        Trans R Soc Trop Med Hyg. 1987; 81: 816-820
        • Kurane I.
        • Ennis F.A.
        Immunity and immunopathology in dengue virus infections.
        Semin Immunol. 1992; 2: 121-127
        • Kurane I.
        • Ennis F.A.
        Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever.
        Semin Virology. 1994; 5: 443-448
        • Halstead S.B.
        • Dengue viruses
        Gorbach S.L. Bartlett J.G. Blacklow N.R. Infectious diseases. WB Saunders, Philadelphia1992: 1830-1835
        • Guzman M.G.
        • Kourí G.
        • Bravo J.
        • Soler M.
        • Martinez E.
        Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic.
        Mem Inst Oswaldo Cruz. 1991; 86: 367
        • Guzman M.G.
        • Kourí G.
        • Bravo J.
        • Soler M.
        • Vazquez S.
        • Morier L.
        Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study.
        Am J Trop Med Hyg. 1990; 42: 179-184
        • Chungue E.
        • Cassar O.
        • Drouet M.T.
        • et al.
        Molecular epidemiology of dengue 1 and dengue 4 viruses.
        J Gen Virol. 1995; 76: 1877-1884
        • Guzmán M.G.
        • Deubel V.
        • Pelegrino J.L.
        • et al.
        Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic.
        Am J Trop Med Hyg. 1995; 52: 241-246
        • Rico-Hesse R.
        • Harrison L.M.
        • Salas R.A.
        • et al.
        Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas.
        Virology. 1997; 230: 244-251
        • Innis B.L.
        Dengue and dengue hemorrhagic fever. Exotic viral infections.
        in: Porterfield J.S. Chapman & Hall, London1995: 103-140

      Article info

      Publication history

      Accepted: January 14, 1999
      Received: December 31, 1998

      Identification

      DOI: https://doi.org/10.1016/S1201-9712(99)90033-4

      Copyright

      © 1999 Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX